SEC Form 4 · accession 0001645627-17-000020
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Mar 23, 2017
Accepted (ET)
Mar 23, 2017 · 2:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 23, 2017 | P | 1,000 | $0.059 | A | 19,847,649 | D | |
| Common Stock | Mar 23, 2017 | P | 1,000 | $0.06 | A | 19,848,649 | D | |
| Common Stock | Mar 23, 2017 | P | 1,000 | $0.06 | A | 19,849,649 | D | |
| Common Stock | Mar 23, 2017 | P | 1,000 | $0.0583 | A | 19,850,649 | D | |
| Common Stock | Mar 23, 2017 | P | 1,000 | $0.0585 | A | 19,851,649 | D | |
| Common Stock | Mar 23, 2017 | P | 1,000 | $0.0585 | A | 19,852,649 | D | |
| Common Stock | Mar 23, 2017 | P | 1,000 | $0.0585 | A | 19,853,649 | D | |
| Common Stock | Mar 23, 2017 | P | 1,000 | $0.0585 | A | 19,854,649 | D |
Table II — derivative securities
No Table II lines on this filing.